Substantial intentional weight loss and mortality in the severely obese

Annals of Surgery

Volumn 246, Issue 6, 2007, Pages 1028-1033

  Peeters, Anna ^a,b   O'Brien, Paul E ^a,h   Laurie, Cheryl ^a   Anderson, Margaret ^a   Wolfe, Rory ^b   Flum, David ^c,d   MacInnis, Robert J ^e,f,g   English, Dallas R ^e,f   Dixon, John ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e CANCER EPIDEMIOLOGY CENTRE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BARIATRIC SURGERY; BODY MASS; COMORBIDITY; FEMALE; GASTRIC BANDING; GENDER; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL TIME; VITAL STATISTICS; WEIGHT REDUCTION;

ADULT; AGED; BARIATRIC SURGERY; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; VICTORIA; WEIGHT LOSS;

EID: 36549086016     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31814a6929     Document Type: Article

References (39)

1. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
2. Mokdad AH, Serdula MK, Dietz WH, et al. The continuing epidemic of obesity in the United States. JAMA. 2000;284:1650-1651.
3. Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530-1538.
4. van Dam R, Willett W, Manson JE, et al. The Relationship between overweight in adolescence and premature death in women. Ann Int Med. 2006;145:91-97.
5. Freedman DM, Ron E, Ballard-Barbash R, et al. Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond). 2006;30:822-829.
6. Williamson DF, Pamuk E, Thun M, et al. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol. 1995;141:1128-1141.
7. Williamson DF. Intentional weight loss: patterns in the general population and its association with morbidity and mortality. Int J Obes Relat Metab Disord. 1997;21(suppl 1):S14-19; discussion S20-21.
8. Williamson DF, Pamuk E, Thun M, et al. Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. Am J Epidemiol. 1999;149:491-503.
9. Williamson DF, Thompson TJ, Thun M, et al. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care. 2000;23:1499-1504.
10. Droyvold WB, Lund Nilsen TI, Lydersen S, et al. Weight change and mortality: the Nord-Trondelag Health Study. J Intern Med. 2005;257:338-345.
11. Meltzer AA, Everhart JE. Unintentional weight loss in the United States. Am J Epidemiol. 1995;142:1039-1046.
12. Wannamethee SG, Shaper AG, Walker M. Weight change, weight fluctuation, and mortality. Arch Intern Med. 2002;162:2575-2580.
13. Wannamethee SG, Shaper AG, Lennon L. Reasons for intentional weight loss, unintentional weight loss, and mortality in older men. Arch Intern Med. 2005;165:1035-1040.
14. Christou NV, MacLean LD. Effect of bariatric surgery on long-term mortality. Adv Surg. 2005;39:165-179.
15. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416-423; discussion 423-424.
16. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543-551.
17. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
18. Giles GG, English DR. The Melbourne collaborative cohort study. IARC Sci Publ. 2002;156:69-70.
19. Lohman T, Roche A, Matorell R. Anthropometric Standardization Reference Manual. Champaign, IL: Kinetics Books; 1988.
20. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-241.
21. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
22. Adams T, Gress R, Smith S, et al. Long-term mortality following gastric bypass surgery. Obes Rev. 2006;7:94.
23. Busetto L, Mazza M, Mirabelli D, et al. Total mortality in morbid obese patients treated with laparascopic adjustable banding: a case-control study. Obes Rev. 2006;7:95.
24. Sjostrom L. Soft and hard endpoints over 5-18 years in the intervention trial Swedish obese subjects. Obes Rev. 2006;7:27.
25. Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293:1861-1867.
26. Roth GS, Ingram DK, Lane MA. Caloric restriction in primates and relevance to humans. Ann N Y Acad Sci. 2001;928:305-315.
27. Brook RD. Obesity, weight loss, and vascular function. Endocrine. 2006;29:21-25.
28. Gokce N, Vita JA, McDonnell M, et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol. 2005;95:266-268.
29. Dixon JB, O'Brien PE. Lipid profile in the severely obese: changes with weight loss after lap-band surgery. Obes Res. 2002;10:903-910.
30. Heilbronn LK, Smith SR, Ravussin E. The insulin-sensitizing role of the fat derived hormone adiponectin. Curr Pharm Des. 2003;9:1411-1418.
31. Kopp HP, Krzyzanowska K, Mohlig M, et al. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond). 2005;29:766-771.
32. Lane MA, Ingram DK, Ball SS, et al. Dehydroepiandrosterone sulfate: a biomarker of primate aging slowed by calorie restriction. J Clin Endocrinol Metab. 1997;82:2093-2096.
33. Dixon JB, O'Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg. 2002;184:51S-54S.
34. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
35. Mertens IL, Van Gaal LF. Overweight, obesity, and blood pressure: the effects of modest weight reduction. Obes Res. 2000;8:270-278.
36. Blackburn G. Effect of degree of weight loss on health benefits. Obes Res. 1995;3(suppl 2):211S-216S.
37. Chapman A, Kiroff G, Game P. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic review. Surgery. 2004;135:326-351.
38. Jick H, Vasilakis C, Weinrauch L, et al. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. N Engl J Med. 1998;339:719-724.
39. Li Z, Maglione M, Tu W. Meta-analysis: pharmacologic treatment of obesity. Ann Int Med. 2005;142:532-546.